Ibrahim, Supapitch Sirimangklanurak, Allan Bueso, Daniel M
Questions to raise include whether the trial is legitimate, which condition it studies, what visits are required, what monitoring is included, and how adverse effects are handled
Results From 3,635 patients, 3,408 patients completed the DLQI questionnaire with no missing data
This can include individuals who are sensitive to medication side effects, have experienced difficulty tolerating standard GLP-1 dose escalation, or are looking for a lower-intensity approach under medical supervision
Titration Phase After four weeks of treatment, the semaglutide dosage is increased to 0.5 mg once a week
Your healthcare provider can help determine appropriate management strategies